Immix Biopharma Inc

NAS:IMMXHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$8.35−1.88%At closeAt close · Fri 23 Oct · ≈ AED 30.67 · Market cap $692.24M · Next earnings Fri 6 Nov · Extended $8.40 +0.60%

USD millions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	TTM	YoY
Revenue	0.0	0.0	0.0	0.0	0.0	0.0	0.0	—
Cost of revenue	0.0	0.0	0.0	0.0	0.0	0.4	0.5	+33.6%
Gross profit	0.0	0.0	0.0	0.0	0.0	(0.4)	(0.5)	−33.6%
Research & development	0.2	0.1	4.2	8.7	11.3	16.3	21.6	+33.0%
Selling, general & administrative	0.2	1.2	4.0	7.4	11.4	13.7	—	—
Selling & marketing	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Operating expenses	0.5	1.4	8.2	16.1	22.7	26.8	41.7	+55.3%
Operating income	(0.5)	(1.4)	(8.2)	(16.1)	(22.7)	(27.2)	(41.8)	−53.7%
Interest expense	0.1	0.2	0.0	0.0	0.0	0.0	0.0	—
Interest income	0.0	0.0	0.0	0.6	1.0	0.6	1.9	+247.8%
Other income / expense	(0.7)	(23.0)	(0.0)	0.6	1.0	(2.2)	—	—
Pre-tax income	(1.1)	(24.4)	(8.2)	(15.6)	(21.7)	(29.4)	(39.9)	−35.7%
Income tax	0.0	0.0	0.0	0.0	0.0	0.0	0.0	−11.7%
Net income	(1.1)	(24.4)	(8.2)	(15.4)	(21.6)	(29.4)	(39.9)	−35.5%
Discontinued operations	0.0	0.0	0.0	0.0	0.0	0.0	—	—
Other net income adjustments	0.0	0.0	0.0	0.0	0.0	0.0	—	—
EPS, basic (per share)	(0.15)	(6.64)	(0.59)	(0.89)	(0.76)	(0.89)	(0.88)	+1.2%
EPS, diluted (per share)	(0.15)	(6.64)	(0.59)	(0.89)	(0.76)	(0.89)	(0.88)	+1.2%
EBITDA	(0.5)	(24.2)	(8.2)	(15.6)	(21.5)	(29.0)	(40.7)	−40.3%
Depreciation & amortization	0.0	0.0	0.0	0.0	0.1	0.4	0.4	+1.7%
Weighted average shares (shares)	7,773,750	3,672,611	13,887,309	17,341,000	28,285,637	32,965,706	—	—
Weighted average diluted shares (shares)	7,773,750	3,672,611	13,887,309	17,341,145	28,285,637	32,965,706	—	—